Zhang W, Na T, Peng J-B. WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway. Am J Physiol Renal Physiol 295: F1472-F1484, 2008. First published September 3, 2008 doi:10.1152/ajprenal.90229.2008 absorption. The kinase domain of WNK3 alone was sufficient to increase TRPV5-mediated Ca 2ϩ transport, and the positive regulatory effect was abolished by the kinase-inactive D294A mutation in WNK3, indicating a kinase-dependent mechanism. The complexly glycosylated TRPV5 that appears at the plasma membrane was increased by WNK3. The exocytosis of TRPV5 was increased by WNK3, and the effect of WNK3 on TRPV5 was abolished by the microtubule inhibitor colchicine. The increased plasma membrane expression of TRPV5 was likely due to the enhanced delivery of mature TRPV5 to the plasma membrane from its intracellular pool via the secretory pathway. These results indicate that WNK3 is a positive regulator of the transcellular Ca 2ϩ transport pathway. While clinical manifestations such as hyperkalemia, hypertension, mild metabolic acidosis, low renin, and normal glomerular filtration rate are commonly present in FHH (23), patients with Q565E mutation in WNK4 also exhibit hypercalciuria and hypersensitivity to thiazide diuretics (37, 38), whereas patients with WNK1 mutation do not show urinary calcium wasting (1). The nature of electrolyte imbalance in FHH motivated the studies on the effects of WNKs on ion transport proteins. WNK4 was shown to inhibit the thiazide-sensitive Na-Cl cotransporter (NCC) (5,21,22,61,(67)(68)(69) and other members of the SLC12A family (20, 28), the renal outer medullary K ϩ channel (ROMK) (24,31,50), the epithelial sodium channel (ENaC) (16,49,50), and osmolarity-sensitive calcium-permeable channel TRPV4 (17), and to enhance epithelial calcium channel TRPV5 (27). WNK1, on the other hand, regulates ENaC (41,64,65) and ROMK (11,33,59) in a manner independent of its kinase activity. In addition, WNK4 and WNK1 also regulate paracellular Cl Ϫ permeability through regulating the claudins (29,42,66). Both WNK1 and WNK4 can also regulate SLC12A members through the activation of STE20 kinases (2,18,40,57,58). Misregulation of NCC by WNK4 mutants was confirmed in transgenic mouse studies and is most relevant to the pathogenesis of FHH (32, 70). WNK3 has been shown to be a potent regulator of the SLC12A family of electroneutral cation/Cl Ϫ cotransporters in a kinase-dependent manner (12,30,47,48). In contrast to the effects of WNK3 on SLC12A family members, WNK3 decreases the plasma membrane expression of ROMK1 independent of its kinase activity (34). Similarly, the Cl Ϫ channel SLC26A9 is also inhibited by WNK3 in a kinase-independent manner (14).TRPV5 and TRPV6 are Ca 2ϩ -selective channels, which mediated the apical Ca 2ϩ entry process of the transcellular calcium transport pathway in the kidney and intestine, respectively (25, 45). TRPV5 knockout mice exhibit a 6-to 10-fold increase in urinary Ca 2ϩ excretion (26); and TRPV6 knockout mice show a 60% reduction ...